Lapatinib inhibits receptor phosphorylation and cell growth and enhances antibody‐dependent cellular cytotoxicity of EGFR‐ and HER2‐overexpressing esophageal cancer cell lines
Kousaku Mimura(Fukushima Medical University), Hideki Fujii(University of Yamanashi)
Cited by 69
Related Papers
<scp>PD</scp>‐L1 expression is mainly regulated by interferon gamma associated with <scp>JAK</scp>‐<scp>STAT</scp> pathway in gastric cancer
|Cancer Science|2017|320
The MAPK Pathway Is a Predominant Regulator of HLA-A Expression in Esophageal and Gastric Cancer
|The Journal of Immunology|2013|90
Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer
|International Journal of Cancer|2014|55